In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Amyris, Sanofi-Aventis, and non-profits in malaria drug deal

Executive Summary

Sanofi-Aventis, Amyris (synthetic biology for drug and chemical production), the Institute for OneWorld Health (iOWH), and the University of California, Berkeley have agreed to work together on the development, manufacturing, and commercialization of a semisynthetic artemisinin for use in malaria treatments.
Deal Industry
  • Biotechnology
    • Synthesis Technologies, Production Processes
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Alliance
    • R+D and Marketing-Licensing

Related Companies